These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 15306569)

  • 1. Guidelines for the management of inflammatory bowel disease in adults.
    Carter MJ; Lobo AJ; Travis SP;
    Gut; 2004 Sep; 53 Suppl 5(Suppl 5):V1-16. PubMed ID: 15306569
    [No Abstract]   [Full Text] [Related]  

  • 2. Refractory inflammatory bowel disease in children.
    Oliva-Hemker M; Escher JC; Moore D; Dubinksy M; Hildebrand H; Koda YK; Murch S; Sandhu B; Seo JK; Tanzi MN; Warner B;
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):266-72. PubMed ID: 18664886
    [No Abstract]   [Full Text] [Related]  

  • 3. Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): the missing term in the literature.
    Peyrin-Biroulet L
    Am J Gastroenterol; 2013 May; 108(5):859-60. PubMed ID: 23644972
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis].
    Fiasse R; Denis MA; Dewit O
    J Pharm Belg; 2010 Mar; (1):1-9. PubMed ID: 20432590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease: short- and long-term treatments.
    Bickston SJ; Cominelli F
    Adv Intern Med; 1998; 43():143-74. PubMed ID: 9506181
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 7. [Budesonide: effective, with low side effects. On the road to new treatment methods in Crohn disease].
    Internist (Berl); 1998 Sep; 39(9 Suppl Auf Dem We):1-8. PubMed ID: 9772715
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.
    Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Budesonide and inflammatory bowel disease].
    Gomollón F; Hinojosa J; Nos P
    Gastroenterol Hepatol; 1999 Dec; 22(10):525-32. PubMed ID: 10650668
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases].
    Kruis W; Pohl C
    Dtsch Med Wochenschr; 1998 Jan; 123(4):85-7. PubMed ID: 9487288
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inflammatory bowel disease: an overview].
    Herrlinger K
    Med Monatsschr Pharm; 2013 Nov; 36(11):402-8; quiz 409. PubMed ID: 24640117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changing treatment of inflammatory bowel diseases].
    Karvonen AL; Matikainen M; Turunen U
    Duodecim; 1994; 110(20):1945-54. PubMed ID: 7555809
    [No Abstract]   [Full Text] [Related]  

  • 13. [Surgery--indispensable complement ot drug therapy].
    Andersson MV; Andersson P; Bohe M; Börjesson L; Graf W; Jeppsson B; Törkvist L; Akerlund JE; Söderholm JD
    Lakartidningen; 2009 Nov 4-12; 106(45):3003-9. PubMed ID: 19998827
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab in ulcerative colitis.
    Aberra FN; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corticoids in intestinal inflammatory diseases: use].
    Modigliani R
    Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B169-77. PubMed ID: 10897789
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of colitis ulcerosa and Crohn's disease].
    Kovács A
    Orv Hetil; 2006 Apr; 147(16):755-8. PubMed ID: 16711262
    [No Abstract]   [Full Text] [Related]  

  • 17. Personalizing therapy for inflammatory bowel diseases.
    Ananthakrishnan AN
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):549-58. PubMed ID: 23985004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the dose of thioguanine the key to better safety profile?
    Chevaux JB; Peyrin-Biroulet L
    Dig Liver Dis; 2011 Feb; 43(2):96-7. PubMed ID: 21156354
    [No Abstract]   [Full Text] [Related]  

  • 19. Is keeping the colon the ultimate marker of success in ulcerative colitis?
    Nguyen GC; Prather CM
    Gastroenterology; 2009 Oct; 137(4):1204-6. PubMed ID: 19717125
    [No Abstract]   [Full Text] [Related]  

  • 20. How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel Diseases.
    Schreiber S; Vermeire S
    Gastroenterology; 2016 May; 150(5):1061-1066. PubMed ID: 27018485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 45.